Employer record · Lexington, MA · FY2020–FY2026

Agenus Inc.

    USCIS approval rateFY24–26 · 5 approved

    Certified LCAs
    6
    FY2024–FY2026
    USCIS approvals
    5
    1 new employment
    Denial rate
    0.0%
    FY2024–FY2026
    Median wage offered
    $171k
    certified LCAs

    Does Agenus Inc. sponsor H-1B visas?

    Yes — by its record, Agenus Inc. is a small-scale H-1B sponsor: it filed 6 certified Labor Condition Applications (LCAs) in FY2024–FY2026 and received 5 USCIS H-1B petition approvals (1 for new employment). Its latest certified LCA in our data was decided Nov 14, 2025. Past filings are history, not a promise: they do not mean the employer will sponsor you or a given role.

    Updated · DOL OFLC LCA disclosure + USCIS H-1B Employer Data Hub

    Filings by fiscal year

    Certified LCAs per U.S. government fiscal year (Oct–Sep) — 25 since FY2020; the slim bar is USCIS petition approvals (new + continuing), the bottom row their approval rate.

    Agenus Inc. certified LCAs by fiscal year
    Fiscal yearcertified LCAsUSCIS approvalsApproval rate
    FY2043100%
    FY2147100%
    FY227375%
    FY2341100%
    FY2412100%
    FY2542100%
    FY2611100%

    Occupations sponsored

    Occupation (SOC)LCAsMedian wage
    Regulatory Affairs Managers 11-91992$191k
    Statisticians 15-20412$250k
    Natural Sciences Managers 11-91211$129k
    Data Scientists 15-20511$151k

    Most-filed job titles

    1. Director, Pharmacovigilance2$191k
    2. Biostatistics Manager1$128k
    3. Clinical Trial Manager1$129k
    4. Senior Director, Statistical Programming1$250k
    5. Senior Manager, Clinical Data Science1$151k

    LCAs per title and median wage offered.

    Where the jobs were

    1. New Jersey3 LCAs
    2. Washington1 LCAs
    3. Delaware1 LCAs
    4. Arizona1 LCAs

    No open jobs listed right now

    Either we don't crawl this employer's career site yet, or it has no US openings. Its filing record above is still current.

    Search all open jobs

    Also filed as

    • AGENUS INC (USCIS)
    • Agenus Inc. (LCA)

    Agenus Inc. H-1B: questions people ask

    Does Agenus Inc. sponsor H-1B visas?

    Yes — by its record, Agenus Inc. is a small-scale H-1B sponsor: it filed 6 certified Labor Condition Applications (LCAs) in FY2024–FY2026 and received 5 USCIS H-1B petition approvals (1 for new employment). Its latest certified LCA in our data was decided Nov 14, 2025. Past filings are history, not a promise: they do not mean the employer will sponsor you or a given role.

    Is Agenus Inc. still sponsoring H-1B in 2026?

    Agenus Inc. had 1 certified LCAs in FY2026 (Oct 2025–Sep 2026), fewer than the 4 in FY2025. The latest one in our data was decided Nov 14, 2025. An LCA is filed before a petition, so it shows recent intent to hire on H-1B, not a hire.

    How many H-1B petitions does Agenus Inc. get approved?

    USCIS recorded 5 approvals (1 for new employment, the rest continuing employment such as extensions and transfers) and 0 denials for Agenus Inc. in FY2024–FY2026 — a denial rate of 0.0%. Source: USCIS H-1B Employer Data Hub (first decisions).

    What is the H-1B salary at Agenus Inc.?

    The median wage offered on Agenus Inc.'s certified LCAs in FY2024–FY2026 was $171k a year. By job title: Director, Pharmacovigilance $191k (2 LCAs), Biostatistics Manager $128k (1 LCAs) and Clinical Trial Manager $129k (1 LCAs). LCA wages are the pay the employer attested to; actual pay can be higher.

    Which jobs does Agenus Inc. sponsor for H-1B?

    Its certified LCAs in FY2024–FY2026 were mostly for Regulatory Affairs Managers (2), Statisticians (2) and Natural Sciences Managers (1).

    Where are Agenus Inc.'s H-1B jobs?

    By worksite on its certified LCAs (FY2024–FY2026): New Jersey (3), Washington (1), Delaware (1) and Arizona (1).

    Is Agenus Inc. an H-1B dependent employer?

    No — its recent LCAs do not declare it H-1B dependent.

    Does Agenus Inc. have open jobs?

    We list no open US jobs for Agenus Inc. right now — either we don't crawl its career site yet or it has no US openings.